Assetmark »

Telix Pharmaceutical Ltd Sponsored shares owned by Assetmark

Quarter-by-quarter ownership of Telix Pharmaceutical Ltd Sponsored (TLX) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Telix Pharmaceutical Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Telix Pharmaceutical Ltd Sponsored held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telix Pharmaceutical Ltd Sponsored by Assetmark

Quarter filed Position value Share count Share price at filing
2025-12-31 $337 45 7.49
2025-09-30 $392 41 9.56
2025-06-30 $289 18 16.06

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Microsoft Corporation (MSFT)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Meta Platforms Cl A (META)

View all positions for Assetmark

Top funds holding Telix Pharmaceutical Ltd Sponsored

Portland Investment Counsel
Lazard Asset Management
Millennium Management
FMR
Marshall Wace
Private Advisor
Jane Street
Quadrature Capital
Mariner Wealth Advisors
Vident Advisory
Jpmorgan Chase & Co
IHT Wealth Management
Point72 Asset Management
JustInvest
Old Mission Capital

View all funds holding Telix Pharmaceutical Ltd Sponsored